The healthcare landscape is rapidly evolving, and recent developments suggest the potential arrival of copyright in a 3mg oral form. Currently, Novo Nordisk is primarily available as an pen, which can be the barrier for many patients. The potential ingested option – if authorized – could provide a more and less way of administration for individ